SCHEMBL20041847

SCHEMBL20041847

CCC(CNC=O)c1ccc(OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.45
AOC3 Q16853 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ACHE P22303 1/20 0.41
MIF P14174 1/20 0.40
ALDH1A1 P00352 4/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP17A1 P05093 1/20 0.39
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38
ADRB2 P07550 1/20 0.37
FAAH O00519 1/20 0.37
AKR1C3 P42330 2/20 0.37
AKR1C2 P52895 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3443780 0.79 AOC3 (0.63) AOC3ALDH1A1GAAMAPTADRB2
SCHEMBL6211895 0.79 ALDH1A1 (0.50) L3MBTL1ALDH1A1GAAKMT2A
SCHEMBL4705880 0.78 FFAR1 (0.53) FFAR1AOC3L3MBTL1CA1CA2
SCHEMBL21988157 0.78 FFAR1 (0.48) FFAR1L3MBTL1CA1CA2MIF
SCHEMBL4723219 0.77 CNR2 (0.49) L3MBTL1ALDH1A1GAAMAPTKMT2A
SCHEMBL28232253 0.75 FFAR1 (0.51) FFAR1AOC3L3MBTL1CA1CA2
SCHEMBL19559551 0.74 TAAR1 (0.36) L3MBTL1ALDH1A1KMT2A
SCHEMBL7055084 0.72 MTNR1A (0.54) ALDH1A1GAAMAPTKMT2A
SCHEMBL6325580 0.72 TAS1R3 (0.44) CA1CA2ALDH1A1CYP2A6TAS1R3
SCHEMBL2169972 0.72 L3MBTL1 (0.47) FFAR1AOC3L3MBTL1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305763-A1 DEUTERATED OR ISOTOPICALLY LABELED UREA DERIVATIVES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF USEFUL AS FPRL-1 AGONISTS Kyorin Pharmaceutical Co., Ltd. (JP) 2018-04-11 EP disclosed